Vicken Karageozian

Company: Allegro Ophthalmics

Job title: CEO

Seminars:

Panel Discussion: Navigating What Design Elements are Needed to Optimize Clinical Trials for Dry AMD? 5:15 pm

Understanding the optimal inclusion and exclusion criteria Considering how the heterogenicity of clinical symptoms, diagnosis and manifestation should impact early and latestage clinical trial planning Assessing the feasibility of having smaller scale clinical trialsRead more

day: Conference Day 1

Comparing the Opportunities Available in Intermediate AMD and Geographic Atrophy 8:30 am

Delving into the differences faced in patient recruitment for iAMD and GA Understanding how the perspectives of the FDA differ between iAMD and GA Identifying the key differences in end points for iAMD and GARead more

day: Conference Day 2

Roundtable Discussion: Exploring the Mechanisms of the Different Causes of Dry AMD 10:00 am

As more therapeutics are progressing through company pipelines, it is more important than ever to have a clear understanding on the mechanistic causes of dry AMD Explore the evidence for the different mechanisms being involved in dry AMD Assess the current preclinical models for representing the different mechanism Discover the potential therapies available to target…Read more

day: Conference Day 2